Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

Completed · Phase 3

Conditions studied: Bipolar Disorder

In brief

The purpose of this study is to evaluate the effectiveness and tolerability of an investigational drug for the treatment of manic episodes of bipolar disorder. The investigational drug will be given as additional therapy to one of the five following medications: risperidone, olanzapine, quetiapine, ziprasidone, or aripiprazole. These medications are already FDA (Food and Drug Administration)-approved treatments for mania.

Key facts

Study ID

NCT00107939

Run by

Novartis Pharmaceuticals

People needed

453

Starts

2004-11-01

Expected to finish

2007-04-01

Last updated by the study team

2017-03-22

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of bipolar disorder (type I) with manic or mixed episodes (including patients with/without psychotic features or with/without a history of rapid cycling)
• In need of psychiatric treatment
• Cooperation and willingness to complete all aspects of the study

You may not qualify if…

• Current diagnosis other than bipolar I disorder
• History of schizophrenia or schizoaffective disorder
• Drug dependence within 1 month prior to study start or testing positive in a urine drug test
• Suicide attempt within 1 month prior to study start or at immediate risk of harm to self or others
• Any form of psychotherapy within 1 month prior to study start

Where it is running

• Investigational Site — Little Rock, Arkansas, United States
• Investigational Site — Orange, California, United States
• Investigational Site — Pico Rivera, California, United States
• Investigational Site — San Diego, California, United States
• Investigational Site — San Diego, California, United States
• Investigational Site — Boca Raton, Florida, United States
• Investigational Site — Atlanta, Georgia, United States
• Investigational Site — Chicago, Illinois, United States
• Investigational Site — Joliet, Illinois, United States
• Investigational Site — Indianapolis, Indiana, United States
• Investigational Site — Topeka, Kansas, United States
• Investigational Site — Kansas City, Missouri, United States
• Investigational Site — St Louis, Missouri, United States
• Invetigational Site — Brooklyne, New York, United States
• Investigational Site — Cedarhurst, New York, United States
• Investigational Site — New York, New York, United States
• Investigational Site — Cincinnati, Ohio, United States
• Investigational Site — Columbus, Ohio, United States
• Investigational Site — Providence, Rhode Island, United States
• Investigational Site — Bellaire, Texas, United States
• Investigational Site — Bellevue, Washington, United States
• Investigational Site — West Allis, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.